Loading company…
Shanghai Yipu Biotechnology develops molecular diagnostic services and products for cancer detection.
Established in 2018 and based in Shanghai, Shanghai Yipu Biotechnology develops molecular cancer diagnostic services and products. Its offerings include cancer markers, a methylation platform, and screening products for whole cancer, bladder cancer, and cervical cancer. The company reports 20+ clinical partners, 21,000+ clinical samples with double-blind cumulative validation, 25+ patent applications, and 25+ STAMP® all-cancer markers.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in